Science Inventory

DISTRIBUTION OF [14C]ETHANE DIMENTHANESULFONATE IN IMMATURE AND ADULT MALE RATS FOLLOWING AN ACUTE EXPOSURE

Citation:

Laskey, J., W. Kelce, G. Klinefelter, L. Gray, Jr., AND L. Ewing. DISTRIBUTION OF [14C]ETHANE DIMENTHANESULFONATE IN IMMATURE AND ADULT MALE RATS FOLLOWING AN ACUTE EXPOSURE. U.S. Environmental Protection Agency, Washington, D.C., EPA/600/J-95/095.

Description:

In the adult rat, ethane dimethanesulphonate (EDS) reduces testosterone (T) production by killing Leydig cells. Studies have also shown that acute EDS administration produces transient infertility and epididymal effects. Although these later effects were believed to be indirect results of the reduced Leydig cell T production, it was recently found that the epididymal effects were partially a direct result of in vivo EDS treatment (Klinefelter et al., 1992). In contrast to the Leydig cells of the adult rat immature Leydig cells are affected by EDS only at doses 4 to 6-fold higher than those that affect mature Leydig cells. In fact, the Leydig cells of the adult rat seem to be uniquely susceptible to the cytotoxic effects of EDS. Steroidogenesis in other organs like the adrenal and ovary, are unaffected in vivo at doses that eliminate T production in males. In addition, studies have known that doses of EDS that kill Leydig cells in vitro, isolated from the testes of adult rats, have not effect on similarly exposed hepatocytes (Kelce et al., 1992a). Hence, it was the objective of this study to describe the distribution and temporal fate of EDS in target (testis and epididymis) and nontarget tissues in immature and adult male rats, and to determine if this information would explain either the age or tissue related susceptibility to EDS. We have concluded from this study that tissue distribution, integrated in vivo EDS dose, and differences in EDS metabolism are not the only factors contributing to the difference in sensitivity. The information collected in this study will enable us to use in vitro EDS concentrations for examination of the mechanism of action at doses relevant to those produced in vivo.

Record Details:

Record Type:DOCUMENT( REPORT )
Product Published Date:05/24/2002
Record Last Revised:04/16/2004
Record ID: 31571